Galderma Launches ‘Scratch Resistance’ Campaign for Atopic Dermatitis Treatment
The broadcast and digital campaign aims to spotlight the emotional burden of eczema-related itch and promote Galderma’s Nemluvio.
Tag: Nemluvio
All
LatestSorry, No Posts Found
All
Latest
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo
If approved, upadacitinib will be the first systemic medication available for patients with vitiligo, according to the company.
